Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1979 Jul;40(1):81–88. doi: 10.1038/bjc.1979.143

Assays of drug sensitivity for cells from human tumours: in vitro and in vivo tests on a xenografted tumour.

A E Bateman, M J Peckham, G G Steel
PMCID: PMC2009973  PMID: 475962

Abstract

A human tumour which grows as a xenograft in immune-suppressed mice and forms colonies in vitro has been used to test the correlation between 2 methods of exposure of human tumour cells to chemotherapeutic agents. In vivo exposure to drugs was achieved by injection of tumour-bearing mice with each of 8 cytotoxic agents. For the in vitro exposure, cell suspensions were incubated for 1 h with the same series of drugs. The survival of tumour clonogenic cells was assayed in vitro after either treatment or dose-response curves were obtained. The 8 drugs were ranked according to their in vivo effect at doses equitoxic to mice, and according to their in vitro effect at concentrations designed to approximate to levels of drugs in human plasma. The ranks for in vivo and in vitro exposure correlated well.

Full text

PDF
81

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barranco S. C., Haenelt B. R., Gee E. L. Differential sensitivities of five rat hepatoma cell lines to anticancer drugs. Cancer Res. 1978 Mar;38(3):656–660. [PubMed] [Google Scholar]
  2. Benjamin R. S., Riggs C. E., Jr, Bachur N. R. Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function. Cancer Res. 1977 May;37(5):1416–1420. [PubMed] [Google Scholar]
  3. Berry R. J., Laing A. H., Wells J. Fresh explant culture of human tumours in vitro and the assessment of sensitivity to cytotoxic chemotherapy. Br J Cancer. 1975 Feb;31(2):218–227. doi: 10.1038/bjc.1975.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bryan G. T., Worzalla J. F., Gorske A. L., Ramirez G. Plasma levels and urinary excretion of hexamethylmelamine following oral administration to human subjects with cancer. Clin Pharmacol Ther. 1968 Nov-Dec;9(6):777–782. doi: 10.1002/cpt196896777. [DOI] [PubMed] [Google Scholar]
  5. Calvert A. H., Bondy P. K., Harrap K. R. Some observations on the human pharmacology of methotrexate. Cancer Treat Rep. 1977 Dec;61(9):1647–1656. [PubMed] [Google Scholar]
  6. Courtenay V. D., Mills J. An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents. Br J Cancer. 1978 Feb;37(2):261–268. doi: 10.1038/bjc.1978.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Freireich E. J., Gehan E. A., Rall D. P., Schmidt L. H., Skipper H. E. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep. 1966 May;50(4):219–244. [PubMed] [Google Scholar]
  8. Goldsmith M. A., Slavik M., Carter S. K. Quantitative prediction of drug toxicity in humans from toxicology in small and large animals. Cancer Res. 1975 May;35(5):1354–1364. [PubMed] [Google Scholar]
  9. Houghton P. J., Houghton J. A., Taylor D. M. Effects of cytotoxic agents on TdR incorporation and growth delay in human colonic tumour xenografts. Br J Cancer. 1977 Aug;36(2):206–214. doi: 10.1038/bjc.1977.179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. MELLETT L. B., HODGSON P. E., WOODS L. A. Absorption and fate of C14-labeled N,N',N''-triethylenethiophosphoramide (thio-TEPA) in humans and dogs. J Lab Clin Med. 1962 Nov;60:818–825. [PubMed] [Google Scholar]
  11. Mellett L. B. Pharmacodynamic and pharmacokinetic measurements of antitumor agents. Clin Pharmacol Ther. 1974 Jul;16(1):230–242. doi: 10.1002/cpt1974161part2230. [DOI] [PubMed] [Google Scholar]
  12. Mitchell J. S., Dendy P. P., Dawson M. P., Wheeler T. K. Testing anti-cancer drugs. Lancet. 1972 Apr 29;1(7757):955–955. doi: 10.1016/s0140-6736(72)91515-2. [DOI] [PubMed] [Google Scholar]
  13. Nowak K., Peckham M. J., Steel G. G. Variation in response of xenografts of colo-rectal carcinoma to chemotherapy. Br J Cancer. 1978 Apr;37(4):576–584. doi: 10.1038/bjc.1978.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Owellen R. J., Hartke C. A., Hains F. O. Pharmacokinetics and metabolism of vinblastine in humans. Cancer Res. 1977 Aug;37(8 Pt 1):2597–2602. [PubMed] [Google Scholar]
  15. Rutty C. J., Connors T. A. In vitro studies with hexamethylmelamine. Biochem Pharmacol. 1977 Dec 15;26(24):2385–2391. doi: 10.1016/0006-2952(77)90446-4. [DOI] [PubMed] [Google Scholar]
  16. Salmon S. E., Hamburger A. W., Soehnlen B., Durie B. G., Alberts D. S., Moon T. E. Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs. N Engl J Med. 1978 Jun 15;298(24):1321–1327. doi: 10.1056/NEJM197806152982401. [DOI] [PubMed] [Google Scholar]
  17. Steel G. G., Courtenay V. D., Rostom A. Y. Improved immune-suppression techniques for the exongrafting of human tumours. Br J Cancer. 1978 Feb;37(2):224–230. doi: 10.1038/bjc.1978.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Tattersall M. H., Jarman M., Newlands E. S., Holyhead L., Milstead R. A., Weinberg A. Pharmaco-kinetics of melphalan following oral or intravenous administration in patients with malignant disease. Eur J Cancer. 1978 May;14(5):507–513. doi: 10.1016/0014-2964(78)90253-0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES